Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
09 July 2021 - 384
Pharmacokinetic-pharmacodynamic target attainment analyses to support dose selection for nacubactam in combination with cefepime
Sujata M. Bhavnani, S.M. Bhavnani (1), M. Trang (1), J.P. Hammel (1), N. Sato (2), B.D. Vanscoy (1), Y. Nagira (2), K. Kato (2), K. Kondo (2), P.G. Ambrose (1)
09 July 2021 - 379
Pharmacokinetic-pharmacodynamic target attainment analyses to support dose selection for nacubactam in combination with aztreonam
Sujata M. Bhavnani, S.M. Bhavnani (1), M. Trang (1), J.P. Hammel (1), N. Sato (2), B.D. Vanscoy (1), Y. Nagira (2), K. Kato (2), K. Kondo (2), P.G. Ambrose (1)
16 April 2019 - O1060
Pharmacokinetics-pharmacodynamics of the novel beta-lactamase inhibitor GT-055 in combination with the siderophore cephalosporin GT-1
Sujata M. Bhavnani, Brian D. VanScoy, Michael Trang, Haley Conde, Donald Biek, Brendan Hannah, Dirk Thye, Paul G. Ambrose
15 April 2019 - P1945
Population pharmacokinetic analysis for lefamulin using data from healthy volunteers and infected patients
Nikolas J. Onufrak, Harish Ganesan, Wolfgang W. Wicha, Steve P. Gelone, Sujata M. Bhavnani, Christopher M. Rubino
15 April 2019 - P1943
Omadacycline pharmacokinetics: impact of comorbidities
Christopher Rubino, Elizabeth A. Lakota, Lawrence Friedrich, Judith N. Steenbergen, Paul C. McGovern, Evan Tzanis, Sujata M. Bhavnani, Christopher M. Rubino
15 April 2019 - P1944
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, Jeffrey P. Hammel, Elizabeth A. Lakota, Kathryn Liolios, Christopher M. Rubino, Judith N. Steenbergen, Lawrence Friedrich, Evan Tzanis, Paul G. Ambrose
15 April 2019 - P1946
Pharmacokinetic-pharmacodynamic (PK-PD) target attainment analyses to support lefamulin dose justification and susceptibility breakpoint determinations for patients with community-acquired bacterial pneumonia (CABP)
Nikolas J. Onufrak, Sujata M. Bhavnani, Jeffrey P. Hammel, Wolfgang W. Wicha, Susanne Paukner, Helio S. Sader, Christopher M. Rubino, Jennifer Schranz, Steve P. Gelone, Paul G. Ambrose
25 April 2017 - OS1021
Use of pharmacokinetic-pharmacodynamic (PK-PD) target attainment analyses to support the evaluation of intravenous and oral lefamulin dosing regimens for the treatment of patients with community-acquired bacterial pneumonia (CABP)
Sujata M. Bhavnani, Sujata Bhavnani, Li Zhang, Christopher Rubino, Justin C. Bader, Helio S. Sader, Steve Gelone, Wolfgang W. Wicha, Paul G. Ambrose
23 April 2017 - EP0351
Population Pharmacokinetic (PPK) analysis for lefamulin plasma and Epithelial Lining Fluid (ELF) exposures using data from healthy subjects
Sujata M. Bhavnani, Li Zhang, Sujata Bhavnani, Paul G. Ambrose, Steve Gelone, Wolfgang W. Wicha, Christopher Rubino
25 April 2015 - P0246
Relationship between arbekacin exposure and resistance amplification in a hollow-fibre infection model
Sujata M. Bhavnani, VanScoy, Brian *; McCauley, Jennifer; Conde, Haley; Baba, N; Ouchi, S; Bhavnani, Sujata; Ambrose, Paul G.;
25 April 2015 - EV1091
Evaluation of pharmacokinetic-pharmacodynamic (PK-PD) relationships for efficacy amongst oseltamivir-treated paediatric patients
Sujata M. Bhavnani, Bulik, Catharine C. *; Rayner, Craig R.; Hammel, Jeffrey P.; Smith, Patrick F.; Forrest, Alan; VanWart, Scott A.; Kamal, Mohamed A.; Smith, James R.; Ambrose, Paul G.; Bhavnani, Sujata;
25 April 2015 - EV1090
Evaluation of pharmacokinetic-pharmacodynamic (PK-PD) relationships for efficacy amongst oseltamivir-treated adult patients
Sujata M. Bhavnani, Bulik, Catharine C. *; Rayner, Craig R.; Hammel, Jeffrey P.; Smith, Patrick F.; Forrest, Alan; VanWart, Scott A.; Kamal, Mohamed A.; Smith, James R.; Ambrose, Paul G.; Bhavnani, Sujata;
27 April 2013 - P916
Pharmacokinetic-pharmacodynamic (PK-PD) analyses for efficacy and safety of brilacidin (BRI) using data from patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, S.M. Bhavnani*, J.P. Hammel, A. Forrest, M. Melhem, P. Sager, D.M. Jorgensen, P.G. Ambrose (Latham, San Francisco, Radnor, US)
27 April 2013 - P917
Population pharmacokinetic (PPK) analyses of brilacidin using data from healthy subjects and patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, M. Melhem, C.M. Rubino, S.M. Bhavnani, A. Forrest*, D.K. Reynolds, D.M. Jorgensen, B. Korczak, P.G. Ambrose (Latham, Radnor, US)
27 April 2013 - P915
Use of pharmacokinetics-pharmacodynamics (PK-PD) and Monte Carlo simulation (MCS) analyses to support brilacidin (BRI) dose selection for patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, S.M. Bhavnani*, J.P. Hammel, A. Forrest, M. Melhem, P. Sager, K.J. Tack, P.G. Ambrose, D.M. Jorgensen (Latham, San Francisco, Brighton, Radnor, US)
27 April 2013 - P914
Pharmacokinetic-pharmacodynamics (PK-PD) predict a high probability of efficacy for plazomicin against serious infections caused by carbapenem-resistant Enterobacteriaceae (CRE)
Sujata M. Bhavnani, S.A. Van Wart, A. Forrest, G.L. Drusano, S.M. Bhavnani*, C.C. Bulik, C.F. Kostrub, P.G. Ambrose, A. Louie (Latham, Orlando, South San Francisco, US)
27 April 2013 - P900
Pharmacokinetics-pharmacodynamics (PK-PD) of tazobactam (TAZ) in combination with ceftolozane (TOL) in an in vitro infection model
Sujata M. Bhavnani, B. VanScoy, R.E. Mendes, A.M. Nicasio, M. Castanheira, C.C. Bulik, O.O. Okusanya, S.M. Bhavnani, A. Forrest, R.N. Jones, L.W. Friedrich, J.N. Steenbergen, P.G. Ambrose* (Latham, North Liberty, Albany, Lexington, US)
Loading ...
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.